Get started
Tesla at a Critical Level!Tesla is currently sitting at a crucial support level at $205. If the price closes below this level, we could see a retest of $180. A bounce could occur at either $205 or $180, both being strong support levels. Target: Take profit around $296, as indicated by strong resistance at this level. Key Levels: The red lines mark significant support and resistance levels. Rare Scenario: If Tesla breaks below $180, a gap down to $148 might need to be filled, which could present an ultimate buying opportunity. I’m not a financial advisor. Do your own research before making any trades. 📊🚀
NASDAQ:TSLA
by MarketPax
1
6/7/24 - $arlo - rich px 4 implied grow; wait for <$10 minimally6/7/24 - $vrockstar/private - NYSE:ARLO - doing a review today of all IOT-related names given my small 1% (as of now) starter position in NYSE:IOT (go read that for some nuance on sizing). here's a small cap now and my thinking. for now... not worth owning. i need a much better entry. setting target at sub $10 to take a closer look if/when. looks expensive w/ minimal cash gen (ex. stock comp) and between 2-3x sales seems okay generally for this IOT sector, but top line growth has had some severe hiccups, and expected growth is MSD-HSD at best (which might end turning out to be low). i like how the stock/ chart have performed well v the Q's over the last years, but this might just be a function of zip code (IOT) rising tide vs. actual bottoms up fundamentals. it's one i've got on my radar but need to get a better entry.
NYSE:ARLOShort
by VROCKSTAR
INTL closed above resistanceINTL has closed above the 0.382 fib level setting up my second entry along with two continuation gaps. I've placed my Buy order at 26.41, just above yesterdays high and my stop is at 21.36 which is just below the current swing low. INTL has a strong short term trend with the 8 ema above the 21 ema as well as the higher low and higher high. Price is currently in the very large gap of Aug 2024. INTL is a HIGHER risk trade for me based on the previous results. I think they will recover going forward but based on current results and I am underweight on INTL. If the 21 ema closes above the 89 ema i will look to add in again for the longer term trend.
NASDAQ:INTCLong
by WarrenCP
Blue Star Ltd Daily Chart Analysis The daily chart of Blue Star Ltd displays a mixed trend with visible levels of support, resistance, and clear price action signals, indicative of potential breakout and pullback scenarios. Price Action Highlights: 1. Trend Analysis: The stock appears to have been trading within a broad channel, with recent price movements consolidating near a key zone. Multiple trend lines intersect, indicating potential breakout and support zones. 2. Support and Resistance Levels: •Support: The key support level lies around ₹1,775.60, which has previously acted as a strong base for buyers. A breakdown below this level may signal further weakness. •Resistance: Immediate resistance levels are seen around ₹1,888.90 and ₹1,905.80, with a longer-term resistance at ₹2,007.80. A breakout above these levels with strong volume could indicate a bullish reversal. 3.Volume Analysis: The recent spike in volume suggests heightened market activity, typically associated with significant moves. High volume on bullish days can confirm buying interest, whereas volume surges on bearish days may signal distribution. 4.Price Pattern Formation: The chart shows a potential wedge or pennant formation, which often precedes a breakout in either direction. Watching how the price reacts around support and resistance levels will be crucial for determining direction. 5.EMA Levels: The stock is currently trading around the 13, 48, and 200 EMAs, indicating mixed sentiment. A sustained move above these averages, particularly the 200 EMA, would suggest stronger bullish momentum. 6.RSI Indicator: The RSI is around 42.46, indicating the stock is in the lower half of the range, showing mild bearish to neutral momentum. If RSI moves below 40, further bearish pressure could be expected. Conversely, a rise above 50 could indicate a potential bullish reversal. Potential Scenarios: •Bullish Case: A breakout above ₹1,888.90 with strong volume may signal a bullish reversal, targeting ₹2,007.80 and higher in the coming weeks. •Bearish Case: A breakdown below the support of ₹1,775.60 could lead to further downside, potentially testing the lower trendline support around ₹1,600. Summary: Blue Star Ltd is at a crucial juncture, with price action signaling potential for both breakout and consolidation. Traders should closely watch volume, support, and resistance interactions to gauge the direction of the next move. Disclaimer: This analysis is for educational purposes only and should not be considered as financial or trading advice. Please conduct your own research or consult with a financial advisor before making any trading decisions.
NSE:BLUESTARCO
by tintinhawk
Analysis of Strides Pharma (NSE: STAR) - 30-Minute TimeframeHead and Shoulders Pattern: The chart shows a completed head and shoulders pattern, which is typically a bearish reversal pattern indicating a potential decline after an uptrend. The pattern has been completed with the left shoulder, head, and right shoulder visible, followed by a drop confirming the neckline break. Double Bottom Formation: Below the head and shoulders pattern, there is a double bottom pattern (labeled as "Bottom 1" and "Bottom 2"). This pattern suggests that after the decline, the stock found support around the ₹1,450 level and began to rise, indicating a potential reversal from bearish to bullish. The breakout above the neckline of the double bottom is an early bullish signal. Bullish Flag: Currently, the stock is forming a bullish flag pattern, which often suggests continuation after an initial uptrend. This is a consolidation phase before a possible breakout to higher levels. The breakout from this flag could target higher levels around ₹1,600-₹1,650 as marked on the chart. Targets: Short-term Target: If the stock breaks out of the bullish flag, the immediate target is around ₹1,600. Extended Target: With sustained momentum, further targets could be around ₹1,650 and ultimately ₹1,725. Support and Resistance: Support Levels: ₹1,500 acts as an immediate support level. Resistance Levels: The primary resistance is around ₹1,600, with further resistance at ₹1,650. Volume Analysis: Volume analysis indicates a notable increase during the breakout from the double bottom, confirming buying interest. Watch for volume spikes accompanying any breakout from the bullish flag for confirmation. Fundamental Analysis of Strides Pharma Company Overview: Strides Pharma is a prominent player in the pharmaceutical industry, focusing on the development and manufacturing of generics and complex products. The company has a strong presence in regulated markets, including the U.S., Europe, and Australia. Revenue and Earnings: The company has shown steady revenue growth, supported by new product launches and expanding market share. However, earnings can be volatile due to pricing pressures in the U.S. generics market and regulatory changes. Recent quarters have shown signs of recovery in margins due to cost optimization and new high-margin product launches. R&D and Product Pipeline: Strides Pharma invests significantly in research and development, focusing on niche and complex generics that offer competitive advantages and higher margins. This focus positions the company well for future growth in both established and emerging markets. Financial Health: The company maintains a balanced debt-to-equity ratio, but investors should monitor any increase in debt levels, especially for capital expenditure and expansion. Positive cash flow trends in recent quarters have strengthened its financial position, aiding in further R&D investments and market expansion. Sector Outlook: The pharmaceutical sector has strong tailwinds with growing global demand for generic drugs, especially in emerging markets. Strides Pharma, with its broad portfolio and strategic focus, is well-placed to benefit from these trends. Conclusion: Technical Outlook: Strides Pharma is showing a bullish setup with a completed double bottom and a current bullish flag pattern. A breakout from the flag could lead to targets at ₹1,600 and potentially ₹1,725 if the momentum continues. Fundamental Outlook: The company has solid fundamentals, supported by its strategic focus on complex generics and a growing product pipeline. While revenue growth is steady, investors should be aware of market-specific risks such as regulatory challenges.
NSE:STARLong
by TheWealthyInvestorbyDSAB
CAPLIN POINT LAB LTD S/RSupport and Resistance Levels: Support Levels: These are price points (green line/shade) where a downward trend may be halted due to a concentration of buying interest. Imagine them as a safety net where buyers step in, preventing further decline. Resistance Levels: Conversely, resistance levels (red line/shade) are where upward trends might stall due to increased selling interest. They act like a ceiling where sellers come in to push prices down. Breakouts: Bullish Breakout: When the price moves above resistance, it often indicates strong buying interest and the potential for a continued uptrend. Traders may view this as a signal to buy or hold. Bearish Breakout: When the price falls below support, it can signal strong selling interest and the potential for a continued downtrend. Traders might see this as a cue to sell or avoid buying. 20 EMA (Exponential Moving Average): Above 20 EMA(50 EMA): If the stock price is above the 20 EMA, it suggests a potential uptrend or bullish momentum. Below 20 EMA: If the stock price is below the 20 EMA, it indicates a potential downtrend or bearish momentum. Trendline: A trendline is a straight line drawn on a chart to represent the general direction of a data point set. Uptrend Line: Drawn by connecting the lows in an upward trend. Indicates that the price is moving higher over time. Acts as a support level, where prices tend to bounce upward. Downtrend Line: Drawn by connecting the highs in a downward trend. Indicates that the price is moving lower over time. It acts as a resistance level, where prices tend to drop. RSI: RSI readings greater than the 70 level are overbought territory, and RSI readings lower than the 30 level are considered oversold territory. Combining RSI with Support and Resistance: Support Level: This is a price level where a stock tends to find buying interest, preventing it from falling further. If RSI is showing an oversold condition (below 30) and the price is near or at a strong support level, it could be a good buy signal. Resistance Level: This is a price level where a stock tends to find selling interest, preventing it from rising further. If RSI is showing an overbought condition (above 70) and the price is near or at a strong resistance level, it could be a signal to sell or short the asset. Disclaimer: I am not a SEBI registered. The information provided here is for learning purposes only and should not be interpreted as financial advice. Consider the broader market context and consult with a qualified financial advisor before making investment decisions.
NSE:CAPLIPOINT
by zenthosh
TG Therapeutics (TGTX) Analysis Company Overview: TG Therapeutics NASDAQ:TGTX is a biopharmaceutical company focused on developing and commercializing innovative treatments for B-cell diseases. The company's recent FDA approval of BRIUMVI for relapsing multiple sclerosis (RMS) marks a significant milestone, positioning TG Therapeutics to capitalize on a high-demand therapeutic area. Key Developments: FDA Approval of BRIUMVI: The approval of BRIUMVI for relapsing multiple sclerosis opens access to a substantial market, with nearly 1 million individuals in the U.S. affected by RMS. This provides a significant revenue opportunity, with BRIUMVI offering a new treatment option that has shown favorable efficacy, safety, and convenient dosing compared to existing therapies. Positive Market Reception: CEO Michael S. Weiss has expressed strong confidence in BRIUMVI's potential, noting positive feedback from both healthcare providers and patients. The drug's unique value proposition lies in its twice-yearly dosing, which is more convenient than the monthly or quarterly regimens offered by competitors, enhancing patient compliance and satisfaction. Pipeline and Future Growth: The successful launch of BRIUMVI is a testament to TG Therapeutics' ability to introduce novel treatments. This sets a strong foundation for future developments in B-cell disease therapies, as the company explores additional indications and expands its pipeline. BRIUMVI's performance in the market could pave the way for further advancements in TG Therapeutics' product offerings. Investment Outlook: Bullish Outlook: We are bullish on TGTX above the $21.00-$22.00 range, driven by the strong initial reception of BRIUMVI and its potential to capture a significant share of the RMS market. Upside Potential: Our price target for TG Therapeutics is set at $34.00-$35.00, reflecting the expected revenue growth from BRIUMVI and the company's strategic positioning in the biopharma sector. 🚀 TGTX—Leading the Way in B-cell Disease Therapies! #BiopharmaInnovation #MultipleSclerosis #NewTreatmentOptions
NASDAQ:TGTXLong
by Richtv_official
WHIRLPOOL OF INDIA LTD S/RSupport and Resistance Levels: Support Levels: These are price points (green line/shade) where a downward trend may be halted due to a concentration of buying interest. Imagine them as a safety net where buyers step in, preventing further decline. Resistance Levels: Conversely, resistance levels (red line/shade) are where upward trends might stall due to increased selling interest. They act like a ceiling where sellers come in to push prices down. Breakouts: Bullish Breakout: When the price moves above resistance, it often indicates strong buying interest and the potential for a continued uptrend. Traders may view this as a signal to buy or hold. Bearish Breakout: When the price falls below support, it can signal strong selling interest and the potential for a continued downtrend. Traders might see this as a cue to sell or avoid buying. 20 EMA (Exponential Moving Average): Above 20 EMA(50 EMA): If the stock price is above the 20 EMA, it suggests a potential uptrend or bullish momentum. Below 20 EMA: If the stock price is below the 20 EMA, it indicates a potential downtrend or bearish momentum. Trendline: A trendline is a straight line drawn on a chart to represent the general direction of a data point set. Uptrend Line: Drawn by connecting the lows in an upward trend. Indicates that the price is moving higher over time. Acts as a support level, where prices tend to bounce upward. Downtrend Line: Drawn by connecting the highs in a downward trend. Indicates that the price is moving lower over time. It acts as a resistance level, where prices tend to drop. RSI: RSI readings greater than the 70 level are overbought territory, and RSI readings lower than the 30 level are considered oversold territory. Combining RSI with Support and Resistance: Support Level: This is a price level where a stock tends to find buying interest, preventing it from falling further. If RSI is showing an oversold condition (below 30) and the price is near or at a strong support level, it could be a good buy signal. Resistance Level: This is a price level where a stock tends to find selling interest, preventing it from rising further. If RSI is showing an overbought condition (above 70) and the price is near or at a strong resistance level, it could be a signal to sell or short the asset. Disclaimer: I am not a SEBI registered. The information provided here is for learning purposes only and should not be interpreted as financial advice. Consider the broader market context and consult with a qualified financial advisor before making investment decisions.
NSE:WHIRLPOOL
by zenthosh
ITD CEMENTATION INDIA LTD S/RSupport and Resistance Levels: Support Levels: These are price points (green line/shade) where a downward trend may be halted due to a concentration of buying interest. Imagine them as a safety net where buyers step in, preventing further decline. Resistance Levels: Conversely, resistance levels (red line/shade) are where upward trends might stall due to increased selling interest. They act like a ceiling where sellers come in to push prices down. Breakouts: Bullish Breakout: When the price moves above resistance, it often indicates strong buying interest and the potential for a continued uptrend. Traders may view this as a signal to buy or hold. Bearish Breakout: When the price falls below support, it can signal strong selling interest and the potential for a continued downtrend. Traders might see this as a cue to sell or avoid buying. 20 EMA (Exponential Moving Average): Above 20 EMA(50 EMA): If the stock price is above the 20 EMA, it suggests a potential uptrend or bullish momentum. Below 20 EMA: If the stock price is below the 20 EMA, it indicates a potential downtrend or bearish momentum. Trendline: A trendline is a straight line drawn on a chart to represent the general direction of a data point set. Uptrend Line: Drawn by connecting the lows in an upward trend. Indicates that the price is moving higher over time. Acts as a support level, where prices tend to bounce upward. Downtrend Line: Drawn by connecting the highs in a downward trend. Indicates that the price is moving lower over time. It acts as a resistance level, where prices tend to drop. RSI: RSI readings greater than the 70 level are overbought territory, and RSI readings lower than the 30 level are considered oversold territory. Combining RSI with Support and Resistance: Support Level: This is a price level where a stock tends to find buying interest, preventing it from falling further. If RSI is showing an oversold condition (below 30) and the price is near or at a strong support level, it could be a good buy signal. Resistance Level: This is a price level where a stock tends to find selling interest, preventing it from rising further. If RSI is showing an overbought condition (above 70) and the price is near or at a strong resistance level, it could be a signal to sell or short the asset. Disclaimer: I am not a SEBI registered. The information provided here is for learning purposes only and should not be interpreted as financial advice. Consider the broader market context and consult with a qualified financial advisor before making investment decisions.
NSE:ITDCEM
by zenthosh